tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Brett Fishbin, 2 are a HOLD (3.17%), 61 are a BUY (96.83%).
Analyst Brett Fishbin, currently employed at KEYBANK, carries an average stock price target met ratio of 41.85% that have a potential upside of 12.02% achieved within 150 days.
Brett Fishbin’s has documented 122 price targets and ratings displayed on 7 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RMD, ResMed at 07-Aug-2026.
Analyst best performing recommendations are on ICUI (ICU MEDICAL).
The best stock recommendation documented was for ICUI (ICU MEDICAL) at 7/21/2026. The price target of $182 was fulfilled within 17 days with a profit of $23.23 (14.63%) receiving and performance score of 8.61.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 12-Aug-2026
$78.4
$4.15 (5.59%)
$77.53
Buy Since 15-Apr-2019
$85
$10.75 (14.48%)
$80
Buy Since 17-Oct-2022
$82
$7.75 (10.44%)
$82
Buy Since 08-Apr-2022
$98
$23.75 (31.99%)
$95
Hold Since 13-Oct-2025
$78
$10.2 (15.04%)
$90
Which stock is Brett Fishbin is most bullish on?
Which stock is Brett Fishbin is most reserved on?
What Year was the first public recommendation made by Brett Fishbin?
